A review of drug prescribing in children with end-stage renal failure
- 39 Downloads
This review provides a guideline for the prescribing of drugs in children with end-stage renal failure. The altered physiology of renal failure affects the metabolism of most pharmacological agents and modification of the drug dosage or extension of the prescribed drug interval become necessary with declining glomerular filtration rate (GFR). Most dose adjustments are dependent on a knowledge of renal function since GFR is inversely proportioned to the elimination rate constant of a drug. The details of drugs listed by generic name are those commonly used in paediatric practice, and the recommendations for dose adjustments are related to a reduction in GFR and not to body mass. Familiarisation with the normal dose prescription of any drug used in paediatric practice is therefore necessary when referring to the table.
Key wordsDrug prescribing Pharmacokinetics End-stage renal failure
Unable to display preview. Download preview PDF.
- 1.Brater DC, Chennavasin P (1985) Effects of renal disease: pharmacokinetic considerations. In: Benet LZ, Massoud N, Gambertoglio JG (eds) Pharmacokinetic bases for drug treatment. Raven Press, New York. pp 119–147Google Scholar
- 2.Bennett WM (1984) Altering drug dose in patients with diseases of kidney and liver, In: Anderson RJ, Schrier RW (eds) Clinical use of drugs in patients with kidney and liver disease. WB. Saunders, Philadelphia, pp 16–29Google Scholar
- 7.Gibson TP, Nelson HA (1977) Drug kinetics and artificial kidneys, Clin Pharmacolinet 2: 403–416Google Scholar